
CIT GAP Funds invests in TypeZero Technologies
CIT GAP Funds has invested in TypeZero Technologies, LLC, an early-stage medical technology company with a proprietary intelligent control system that improves the safety, outcomes and quality of life for patients with Type 1 and Type 2 diabetes.





